Published in Prev Med on January 01, 1985
Burning Love: big tobacco takes aim at LGBT youths. Am J Public Health (2002) 1.42
Cannabinoid receptor 2-mediated attenuation of CXCR4-tropic HIV infection in primary CD4+ T cells. PLoS One (2012) 1.03
Substance Abuse, Hepatitis C, and Aging in HIV: Common Cofactors that Contribute to Neurobehavioral Disturbances. Neurobehav HIV Med (2012) 0.80
Relationship between pharmacokinetics and hemodynamic effects of inhaled isobutyl nitrite in conscious rats. AAPS PharmSci (2000) 0.77
A new type of synthetic peptide library for identifying ligand-binding activity. Nature (1991) 7.81
Macrophage-lymphocyte interaction in the antigen-induced blastogenic response of human peripheral blood leukocytes. J Immunol (1968) 4.25
The transformation of column-purified lymphocytes with nonspecific and specific antigenic stimuli. J Immunol (1968) 4.24
Deception among smokers. Br Med J (1978) 3.90
Treatment and prophylaxis of disseminated infection due to Candida albicans in mice with liposome-encapsulated amphotericin B. J Infect Dis (1983) 3.86
Impaired in vitro lymphocyte transformation in Hodgkin's disease. N Engl J Med (1965) 3.54
An unusual virus in cultures from a human nasopharyngeal carcinoma. J Natl Cancer Inst (1971) 3.30
Plasma levels of insulin-like growth factor-I and lung cancer risk: a case-control analysis. J Natl Cancer Inst (1999) 2.68
Liposomal amphotericin B for the treatment of systemic fungal infections in patients with cancer: a preliminary study. J Infect Dis (1985) 2.64
A multicenter clinical trial of oral ribavirin in HIV-infected patients with lymphadenopathy. The Ribavirin-LAS Collaborative Group. J Acquir Immune Defic Syndr (1990) 2.57
The human primary immune response to keyhole limpet haemocyanin: interrelationships of delayed hypersensitivity, antibody response and in vitro blast transformation. Clin Exp Immunol (1970) 2.40
Repair of tobacco carcinogen-induced DNA adducts and lung cancer risk: a molecular epidemiologic study. J Natl Cancer Inst (2000) 2.33
Meta- and pooled analysis of GSTT1 and lung cancer: a HuGE-GSEC review. Am J Epidemiol (2006) 2.02
Identifying and recruiting healthy control subjects from a managed care organization: a methodology for molecular epidemiological case-control studies of cancer. Cancer Epidemiol Biomarkers Prev (1997) 1.98
Leukocyte interferon-induced tumor regression in human metastatic breast cancer, multiple myeloma, and malignant lymphoma. Ann Intern Med (1980) 1.91
Benzo[a]pyrene diol epoxide and bleomycin sensitivity and susceptibility to cancer of upper aerodigestive tract. J Natl Cancer Inst (1998) 1.81
Complications of cancer immunotherapy with levamisole. Lancet (1977) 1.76
Marijuana use and increased risk of squamous cell carcinoma of the head and neck. Cancer Epidemiol Biomarkers Prev (1999) 1.72
Lung carcinoma in former smokers. Cancer (1996) 1.70
Homotypic antibody responses to fresh clinical isolates of human immunodeficiency virus. Virology (1991) 1.67
Randomized trial of adjuvant human interferon gamma versus observation in high-risk cutaneous melanoma: a Southwest Oncology Group study. J Natl Cancer Inst (1995) 1.67
Liposome-encapsulated amphotericin B for treatment of disseminated candidiasis in neutropenic mice. J Infect Dis (1984) 1.67
Active immunotherapy with B.C.G. for recurrent malignant melanoma. Lancet (1973) 1.66
Involvement of Jak2 tyrosine phosphorylation in Bcr-Abl transformation. Oncogene (2001) 1.63
History of cigarette smoking and risk of leukemia and myeloma: results from the Adventist health study. J Natl Cancer Inst (1990) 1.60
Immunoglobulin on tumor cells and tumor-induced lymphocyte blastogenesis in human acute leukemia. N Engl J Med (1973) 1.57
Alpha interferon for induction of remission in hairy-cell leukemia. N Engl J Med (1984) 1.57
Ethnic differences in the prevalence of the homozygous deleted genotype of glutathione S-transferase theta. Carcinogenesis (1995) 1.57
Cancer immunotherapy. Can Med Assoc J (1979) 1.54
Evolutionary evidence of the effect of rare variants on disease etiology. Clin Genet (2010) 1.54
Is there a genetic basis for lung cancer susceptibility? Recent Results Cancer Res (1999) 1.53
Progressive disseminated histoplasmosis in patients with acquired immunodeficiency syndrome. Am J Med (1988) 1.48
Chemoimmunotherapy of disseminated malignant melanoma with dimethyl triazeno imidazole carboxamide and bacillus calmette--guérin. N Engl J Med (1974) 1.48
Familial patterns of prostate cancer: a case-control analysis. J Urol (1991) 1.45
Reduced DNA repair capacity in lung cancer patients. Cancer Res (1996) 1.44
Effects of sterols on the therapeutic efficacy of liposomal amphotericin B in murine candidiasis. Cancer Drug Deliv (1983) 1.43
Control of myeloid differentiation and survival by Stats. Oncogene (2000) 1.42
Immunomorphological features of prognostic significance in Dukes' Class B colorectal carcinoma. Cancer Res (1977) 1.40
The C1q binding test for soluble immune complexes: clinical correlations obtained in patients with cancer. J Natl Cancer Inst (1977) 1.40
A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter enhances lung cancer susceptibility. Cancer Res (2001) 1.40
Cells capable of colony formation in the peripheral blood of man. Science (1971) 1.40
Excess leukemia and multiple myeloma in a mining county in northeast Texas. Tex Med (1994) 1.39
GM-CSF, carboplatin, doxorubicin: a phase I study. Cancer Chemother Pharmacol (1994) 1.38
Chemotherapy, immunocompetence, immunosuppression and prognosis in acute leukemia. N Engl J Med (1971) 1.38
Polymorphisms of the DNA repair gene XRCC1 and risk of gastric cancer in a Chinese population. Int J Cancer (2000) 1.37
Testicular cancer associated with employment in agriculture and oil and natural gas extraction. Lancet (1984) 1.35
Ethnic variation in the prevalence of a common NAD(P)H quinone oxidoreductase polymorphism and its implications for anti-cancer chemotherapy. Br J Cancer (1997) 1.32
Antigen dose in the human immune response. Dose-relationships in the human immune response to Keyhole limpet hemocyanin. J Lab Clin Med (1971) 1.32
Chronic immune stimulation by sperm alloantigens. Support for the hypothesis that spermatozoa induce immune dysregulation in homosexual males. JAMA (1984) 1.31
Multiple primary cancer in patients with cancer of the head and neck: second cancer of the head and neck, esophagus, and lung. Int J Radiat Oncol Biol Phys (1989) 1.30
Pulmonary complications of acute leukemia. Cancer (1966) 1.30
Immunological characterization of homosexual males. Cancer Res (1983) 1.29
Patient survival after chemotherapy and its relationship to in vitro lymphocyte blastogenesis. Cancer (1971) 1.29
Reduced DNA repair capacity in head and neck cancer patients. Cancer Epidemiol Biomarkers Prev (1998) 1.28
Chemoimmunotherapy of adult acute leukaemia. Prolongation of remission in myeloblastic leukaemia with B.C.G. Lancet (1974) 1.27
Reduced expression levels of nucleotide excision repair genes in lung cancer: a case-control analysis. Carcinogenesis (2000) 1.26
Idiopathic production of interleukin-1 in acquired immune deficiency syndrome. J Clin Microbiol (1987) 1.26
Polymorphisms of DNA repair gene XRCC1 in squamous cell carcinoma of the head and neck. Carcinogenesis (1999) 1.25
XPD/ERCC2 polymorphisms and risk of head and neck cancer: a case-control analysis. Carcinogenesis (2000) 1.25
Prognostic correlations and response to treatment in advanced metastatic malignant melanoma. Cancer Res (1974) 1.25
Acquired immune deficiency syndrome: postmortem findings. Am J Clin Pathol (1984) 1.24
Clinical pharmacology of 99mTc-labeled liposomes in patients with cancer. Cancer Res (1984) 1.23
Lymphocyte activation: a rapid test to predict allograft rejection. Nature (1970) 1.22
Inhibition of drug-metabolizing enzymes in the rat after Bacillus Calmette-Guérin treatment. Biochem Pharmacol (1976) 1.21
Food group contributions to nutrient intake in whites, blacks, and Mexican Americans in Texas. J Am Diet Assoc (1989) 1.21
An intronic poly (AT) polymorphism of the DNA repair gene XPC and risk of squamous cell carcinoma of the head and neck: a case-control study. Cancer Res (2001) 1.21
Human tumor models in the severe combined immune deficient (scid) mouse. Cancer Chemother Pharmacol (1997) 1.20
Transformation of myeloid leukemia cells to cytokine independence by Bcr-Abl is suppressed by kinase-defective Hck. J Biol Chem (2000) 1.18
The development of breast carcinoma in women with thyroid carcinoma. Cancer (2001) 1.17
Multiple primary neoplasms in blacks compared to whites. 3. Initial cancers of the female breast and uterus. J Natl Cancer Inst (1974) 1.17
Hepatotoxic effects of methotrexate. Cancer (1966) 1.17
Pharmacokinetics of recombinant interleukin 2 in humans. Cancer Res (1990) 1.16
Prophylaxis of Candida albicans infection in neutropenic mice with liposome-encapsulated amphotericin B. Antimicrob Agents Chemother (1984) 1.15
Microbiology experience in collection of human tissue. Am J Clin Pathol (1966) 1.15
The human secondary immune response to Keyhole limpet haemocyanin. Clin Exp Immunol (1972) 1.15
The development of a comprehensive, institution-based patient risk evaluation program: II. Validity and reliability of questionnaire data. Am J Prev Med (1988) 1.14
Sensitivity of multiple myeloma to imexon in the human tumor cloning assay. J Natl Cancer Inst (1994) 1.13
Higher lung cancer risk for younger African-Americans with the Pro/Pro p53 genotype. Carcinogenesis (1995) 1.13
Immune reactivity of lymphoid tissues adjacent to carcinoma of the ascending colon. Surg Gynecol Obstet (1974) 1.13
The covalent coupling of proteins to periodate-oxidized sephadex: a new approach to immunoadsorbent preparation. J Immunol Methods (1976) 1.13
Antibodies to the primary immunodominant domain of human immunodeficiency virus type 1 (HIV-1) glycoprotein gp41 enhance HIV-1 infection in vitro. J Virol (1990) 1.13
American Cancer Society guidelines on diet, nutrition, and cancer. The Work Study Group on Diet, Nutrition, and Cancer. CA Cancer J Clin (1991) 1.13
Lymphadenopathy in homosexual men. Morbid anatomy with clinical and immunologic correlations. Am J Clin Pathol (1983) 1.13
In vitro efficacy of anti-HIV immunotoxins targeted by various antibodies to the envelope protein. J Immunol (1991) 1.12
Increased recovery of Aspergillus flavus from respiratory specimens during hospital construction. Am Rev Respir Dis (1982) 1.12
Plaster-associated Bacillus cereus wound infection. A case report. Orthopedics (1986) 1.12
Special report on Laetrile: the NCI Laetrile Review. Results of the National Cancer Institute's retrospective Laetrile analysis. N Engl J Med (1978) 1.11
Loss of B7.2 (CD86) and intracellular adhesion molecule 1 (CD54) expression is associated with decreased tumor-infiltrating T lymphocytes in diffuse B-cell large-cell lymphoma. Clin Cancer Res (2000) 1.11
Adenocarcinoma of the lung in young patients: the M. D. Anderson experience. Cancer (2000) 1.11
Inhibition of in vitro lymphocyte transformation during chemotherapy in man. Cancer Res (1967) 1.09
Effects of surgery, anesthesia and intraoperative blood loss on immunocompetence. J Surg Res (1973) 1.09
Major head injuries in fights and brawls. Med Sci Law (1968) 1.08
Sensitivity to benzo(a)pyrene diol-epoxide associated with risk of breast cancer in young women and modulation by glutathione S-transferase polymorphisms: a case-control study. Cancer Res (2001) 1.08
Epidemiologic comparison of cancer of the testis and Hodgkin's disease among young males. Cancer (1984) 1.07
Treatment of a presumed case of sympathetic ophthalmia with methotrexate. Arch Ophthalmol (1966) 1.07
Correlation between selected environmental exposures and karyotype in acute myelocytic leukemia. Cancer Epidemiol Biomarkers Prev (1996) 1.07